Coastal Bridge Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.94M Sell
104,583
-1,855
-2% -$49.4K 0.21% 109
2025
Q4
$2.65M Sell
106,438
-29,808
-22% -$752K 0.2% 122
2025
Q3
$3.47M Sell
136,246
-41,004
-23% -$1.01M 0.26% 100
2025
Q2
$4.3M Buy
+177,250
New +$4.13M 0.35% 76
2025
Q1
Sell
-37,862
Closed -$1M 361
2024
Q4
$1M Sell
37,862
-2,507
-6% -$68K 0.25% 65
2024
Q3
$1.17M Buy
40,369
+168
+0.4% +$4.9K 0.29% 59
2024
Q2
$1.12M Hold
40,201
0.28% 58
2024
Q1
$1.12M Buy
40,201
+6,453
+19% +$179K 0.26% 64
2023
Q4
$972K Buy
33,748
+809
+2% +$24.5K 0.25% 66
2023
Q3
$1.09M Buy
32,939
+742
+2% +$26.2K 0.29% 57
2023
Q2
$1.18M Sell
32,197
-2,896
-8% -$113K 0.29% 54
2023
Q1
$1.43M Sell
35,093
-468
-1% -$20.2K 0.36% 47
2022
Q4
$1.82M Sell
35,561
-1,684
-5% -$80.7K 0.52% 37
2022
Q3
$1.63M Buy
37,245
+2,298
+7% +$112K 0.44% 42
2022
Q2
$1.83M Buy
34,947
+734
+2% +$37.4K 0.56% 37
2022
Q1
$1.77M Sell
34,213
-29,844
-47% -$1.55M 0.41% 43
2021
Q4
$3.12M Buy
64,057
+33,345
+109% +$1.65M 0.65% 35
2021
Q3
$1.32M Buy
30,712
+117
+0.4% +$5.18K 0.31% 49
2021
Q2
$1.2M Sell
30,595
-349
-1% -$13.6K 0.25% 54
2021
Q1
$1.12M Buy
30,944
+976
+3% +$34.7K 0.21% 50
2020
Q4
$1.1M Sell
29,968
-6,448
-18% -$237K 0.22% 47
2020
Q3
$1.27M Buy
36,416
+1,197
+3% +$42K 0.39% 39
2020
Q2
$1.09M Buy
35,219
+322
+0.9% +$10.9K 0.35% 44
2020
Q1
$1.08M Buy
34,897
+150
+0.4% +$5.11K 0.4% 40
2019
Q4
$1.29M Sell
34,747
-17
-0% -$606 0.34% 39
2019
Q3
$1.19M Buy
34,764
+283
+0.8% +$10.3K 0.4% 41
2019
Q2
$1.42M Buy
34,481
+160
+0.5% +$6.35K 0.42% 32
2019
Q1
$1.38M Buy
34,321
+112
+0.3% +$4.49K 0.48% 32
2018
Q4
$1.42M Buy
34,209
+102
+0.3% +$4.23K 0.56% 30
2018
Q3
$1.43M Buy
34,107
+3,115
+10% +$120K 0.54% 26
2018
Q2
$1.07M Buy
30,992
+304
+1% +$10.4K 0.43% 35
2018
Q1
$1.03M Buy
30,688
+2,547
+9% +$87.6K 0.38% 37
2017
Q4
$973K Sell
28,141
-2,441
-8% -$83.2K 0.31% 41
2017
Q3
$1.04M Buy
30,582
+121
+0.4% +$3.89K 0.34% 37
2017
Q2
$971K Buy
30,461
+609
+2% +$19.2K 0.33% 33
2017
Q1
$969K Buy
29,852
+117
+0.4% +$3.69K 0.33% 33
2016
Q4
$916K Buy
29,735
+117
+0.4% +$3.57K 0.36% 30
2016
Q3
$952K Buy
29,618
+105
+0.4% +$3.51K 0.46% 18
2016
Q2
$986K Buy
29,513
+105
+0.4% +$3.35K 0.52% 17
2016
Q1
$827K Sell
29,408
-278
-0.9% -$7.94K 0.58% 22
2015
Q4
$909K Buy
+29,686
New +$934K 0.51% 18

Other funds holding PFE

Coastal Bridge Advisors's PFE Position: Q1 2026 in Review

Coastal Bridge Advisors reduced its Pfizer (PFE) stake by 1.7% in Q1 2026, selling an estimated $49.4K and leaving 104,583 shares worth $2.94M. The position accounts for 0.21% of the portfolio, ranked #109.

Coastal Bridge Advisors first reported a position in PFE in Q4 2015 and has held it in 41 quarters since. The position peaked at $4.3M in Q2 2025. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Coastal Bridge Advisors held 104,583 shares of Pfizer worth $2.94M as of Q1 2026.
  • Coastal Bridge Advisors sold 1,855 Pfizer shares in Q1 2026, an estimated $49.4K.
  • Pfizer made up 0.21% of Coastal Bridge Advisors's portfolio in Q1 2026, its #109 holding.
  • Coastal Bridge Advisors first reported a position in Pfizer in Q4 2015 and has held it in 41 quarters since.
  • Coastal Bridge Advisors's Pfizer position peaked at $4.3M in Q2 2025.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Coastal Bridge Advisors's 13F filing for Q1 2026, filed 14 May 2026.